a public good project by the
Synthesis
Company
of California

© 2026

Martin Howard | doi.page

0 works0 citations0 h-index

Martin Howard

AstraZeneca (United Kingdom)(GB)AstraZeneca (Singapore)(SG)AstraZeneca (Switzerland)(CH)

Publications by Year

Research Areas

Palliative Care and End-of-Life Issues, Childhood Cancer Survivors' Quality of Life, Cancer survivorship and care, Chronic Lymphocytic Leukemia Research, Pharmacogenetics and Drug Metabolism

Most-Cited Works

→ Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patients(2003)336 cited
→ Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data(2011)237 cited
→ Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6(2018)136 cited
→ Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy(2010)122 cited
→ Rehabilitation to enable recovery from COVID-19: a rapid systematic review(2021)90 cited
→ Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C(2020)

83 cited

→ Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors(2017)78 cited

→ The Discovery of 7-Methyl-2-[(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one (AZD7648), a Potent and Selective DNA-Dependent Protein Kinase (DNA-PK) Inhibitor(2019)77 cited

→ The Metabolism and Toxicity of Furosemide in the Wistar Rat and CD-1 Mouse: a Chemical and Biochemical Definition of the Toxicophore(2007)71 cited

→ Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study(2018)67 cited